Sun Pharma Acquires Concert for $576 Million
Sun Pharmaceutical Industries, the world’s fourth largest speciality generic drug company, has signed a definitive agreement to acquire US-based Concert Pharmaceuticals for $576 million in...
Download Unicorn Signals App
Powered By EquityPandit
